Pharmaceutical and life science companies spend an absorbent amount of money in research and development to bring their medicines and brands to market only to be diverted or counterfeited. According to the Organization for Economic Cooperation and Development (OECD), the global counterfeit market is worth approximately $461 Billion dollars or roughly 2.5 % of all global trade.
Developing an effective brand protection strategy will defend against counterfeiting, diversion, obsolesce, and maintain brand integrity. CCL Healthcare has protected brands for decades with custom brand security strategies and security solutions. These systems protect the integrity of brands and defend against grey market activities.
CCL is the market leader in brand protection offering a wide range of options that included Overt, Covert, and Forensics security features all manufactured under a cGMP process with a specialization in Track and Trace Serialization. Our customers can be assured that CCL Protects!
Overt, Covert and Forensic Solutions
The correct anti-counterfeit technology and implementation program for your specific market is unique and should be customized based on the threats you face.
However, one thing all successful brand protection strategies have in common is they employ “Layers” of protection. Anti-Counterfeit technology can be classified into 3 primary categories: Overt, Covert and Forensic. Within these 3 primary categories, package component modifications can be customized further to add additional layers of protection. Let CCL guide you through the process.
Recent Blog Posts
Contact us. We'll be with you in no time!